Results 191 to 200 of about 770,024 (305)

Assessing repeatability and confounding factors of magnetic resonance fingerprinting (MRF) for quantitative liver imaging. [PDF]

Med Phys
Lu L, Stephans K, Qiu Z, Tirumani S, Chen Y.   +4 more
europepmc   +1 more source

Confounding factors in the assessment of oral mucositis in head and neck cancer. [PDF]

Support Care Cancer, 2022
Lorini L, Perri F, Vecchio S, Belgioia L, Vinches M, Brana I, Elad S, Bossi P.   +7 more
europepmc   +1 more source

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi, Mohanad A. Alkuwaiti, Yazeed B. Alaql, Ahmed K. Alsaif, Ahmed A. Alessa, Meshari Ayed Alharbi, Mohammed Alfalah, Saud A. Alnaaim, Sajjad M. AlHaddad, Ahmed Y. Azzam   +9 more
wiley   +1 more source

Conformity of spirometric tests with acceptability criteria and assessment of confounding factors in routine clinical practice. [PDF]

Ann Thorac Med
Cengiz SK, Savas IK, Coskun E, Erten HÇ, Cömert SS.   +4 more
europepmc   +1 more source

Determining four confounding factors in individual cognitive traits prediction with functional connectivity: an exploratory study. [PDF]

Cereb Cortex, 2023
Feng P, Jiang R, Wei L, Calhoun VD, Jing B, Li H, Sui J.   +6 more
europepmc   +1 more source

Multiple actors and confounding factors

, 2021
Aaron E. Zazueta, Jeneen R. Garcia
openaire   +2 more sources

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Importance of Accounting for Confounding Factors when Assessing Cardiovascular Outcomes of COVID-19: A Nationwide Cohort Study. [PDF]

Tuberc Respir Dis (Seoul)
You SH, Baek MS, Kim TW, Kim G, Jung SY, Kim WY.   +5 more
europepmc   +1 more source

Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite its monogenic origin, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy exhibits marked variability in clinical expression and severity. Variants in the NOTCH3 gene, within epidermal growth factor‐like repeat domains 1–6 or 7–34, are known to influence disease onset, but their impact ...
Léa Aguilhon, Hugues Chabriat, Dominique Hervé, Stéphanie Guey, Sophie Tezenas Du Montcel, Juliette Ortholand   +5 more
wiley   +1 more source

Enhanced metabolomic predictions using concept drift analysis: identification and correction of confounding factors. [PDF]

Bioinform Adv
Schwarzerova J, Olesova D, Jureckova K, Kvasnicka A, Kostoval A, Friedecky D, Sekora J, Pomenkova J, Provaznik V, Popelinsky L, Weckwerth W.   +10 more
europepmc   +1 more source